Australia’s COVID-19 vaccine rollout commences

The Australian vaccine program began earlier this week, with members of Australia’s most vulnerable community first receiving the Pfizer-BioNTech vaccine.

The global rollout of the COVID-19 vaccine is described as follows: Launch of the largest and most important product in modern history..

At the beginning of the rollout, the professor of immunology Murdoch University Dr. Kathy Berry wanted to reiterate the importance of vaccination against COVID-19.

“Some people are hesitant about new vaccines. They talk to me about mutant virus strains, vaccine novelty, and the short time frame for vaccination deployment in our country, but vaccines. The essence of vaccination is the same regardless of the type of vaccine. It is designed with the special intention of safely training the immune system to win the fight against the virus if exposed in the future. Vaccine-induced antibody and B-cell memory protects and prevents severe COVID, “explained Dr. Berry.

“Vaccination is like hiring a personal trainer for immune health. Individually, the key issue is to develop long-term, broad immunity against the corona virus and evolving variants. Collectively, mass immunity can be achieved to protect individuals who are unable to vaccinate or who are unresponsive to the virus. Immunity simply improves life. “

Associate Professor of Epidemiology La Trobe University Hassan Vally said the official launch of the vaccine in Australia can be seen as a formal entry into the final stages of the pandemic.

“The availability of safe and effective vaccines adds another tool to the toolbox to combat COVID-19. As the vaccine is deployed, it begins to reduce the threat that COVID-19 poses to the community. This means that you can confidently move into your post-pandemic life.

“There’s still a lot to do and we have to put up with it, but vaccination of front-line workers and the most vulnerable people in the community is groundbreaking in terms of responding to COVID-19. It will be important that vaccination of quarantine workers not only reduces the chances of escaping from the hotel, but if that happens, vulnerable people will be vaccinated, so escape The impact will be reduced. We hope this means that there will be less need for a blockade in Australia in the future.

“As the number of people vaccinated increases and the overall threat that the virus poses to us diminishes, the need for restrictions is becoming less and less necessary, so if the community is adequately vaccinated, We look forward to being able to do everything we took for granted 12 months ago, “says Associate Professor Vally.

Dealing with vaccine repellent

Professor Nikolai Petrovsky Flinders University School of Medicine and School of Public Health And research director Vaxin He welcomed the availability of the COVID-19 vaccine in Australia, but said that community uncertainties leading to vaccine hesitation remained a major barrier to full implementation.

“A recent ANU study is uncertain whether a significant portion of the community will be vaccinated. This is because the current government vaccine media campaign may not be effective and the community The evidence from the study that the level of uncertainty has increased rather than decreased in recent months suggests that it can even be counterproductive.

“Successful education campaigns require balancing and addressing known potential benefits in addition to known potential side effects, in addition to ongoing uncertainty about the vaccine being used. There is.

“Because the two vaccines currently available are based on new uses of gene therapy as vaccines, the community is wondering how they differ from traditional vaccines and in terms of the risk-benefit relationship. We need to understand what it means, “explained Professor Nikolai Petrovsky.

“Some people in the community may have decided to wait until a more traditional protein-based vaccine is available after reviewing all the information available. Protein-based vaccines are influenza, It has a long track record of being safely and effectively used against many other infectious diseases such as hepatitis B and human papillomavirus, and has a high level of safety from newborns to the elderly. We have already announced plans to purchase Novavax protein-based vaccines, which may not be far from the release of Phase 3 efficacy data, especially the variety of vaccines offered in Australia. The greater the sex, the easier it will be to achieve the high vaccination rates needed for maximum community protection in the event of further outbreaks in the area.

“Ultimately, the community is affected by the facts, so definitive data showing that vaccines are long-term effective and can prevent infections should be of great help in reducing vaccine hesitation. “

University of Sydney Infectious disease expert Professor Tony Cunningham pointed out the safety profiles of the Pfizer and AstraZeneca vaccines, emphasizing that both vaccines have undergone a full review rather than an emergency. Therapeutic Goods Bureau, And its Phase 3 study data, and ongoing oversight by UK, Israeli, and European regulators will soon be available.

“Pfizer and AstraZeneca vaccine deployments are carefully planned to protect the community so that populations such as quarantine, healthcare, geriatric workers, and geriatric care residents are top priorities. In Australia, follow-up post-rollouts are carefully planned, “says Professor Cunningham.

“The higher efficacy of the AstraZeneca vaccine, which exceeds 80% at 12-week dosing intervals, is highly encouraging and recommended by the TGA. Both vaccines are effective in the latest figures for Israel and the United Kingdom. It looks like, but these are preliminary and may be due in part to the blockade effect. “

Professor Cunningham said the two vaccines were less effective against South African strains in small trials, but as with influenza, all companies on the market are quick to produce second-generation vaccines or boosters. He said he was working on.

Professor Kirsten McCaffery, an Academy Fellow and Health Literacy Researcher at the University of Sydney, emphasized the importance of broadly targeted messaging to address vaccine repellent.

“We need not only a wide range of messages, but also targeted messages for major groups that may be more hesitant. We also need to use social media and mainstream media channels.

“Respecting people who are worried about vaccines is important as well as responding to their questions and needs. Healthcare professionals play an important role here. Sources and trust in health information. People should be encouraged to carefully consider their gender and how they are applied in Australia.

“There is a risk of over-focusing on the minority who are strongly opposed to vaccination. This is when the community comes together and recognizes the remarkable outcomes of the vaccine that will help bring our lives back to normal. . “

Image Credit: © / au / Nadezhda Kozhedub

Australia’s COVID-19 vaccine rollout commences Source link Australia’s COVID-19 vaccine rollout commences

Back to top button